Of course there is possibility of a denial.but I dont see it happening. Very low percentage of that. Buyout is becoming less likely in my opinion. Would've happened by now. If big pharma offers the right price, obviously those making the decision will listen. Chances are if they are waiting for fda approval, then the cost of our company will go through the roof. No one has offered enough at this juncture, they wont offer enough in the future. I think a partnership is more likely. Also the sales ramp up is not too much at this point. We are still very small and the potential of this company is quite large. You could argue that we should have around 1500 to fully capitalize on this market.